269 related articles for article (PubMed ID: 19277236)
1. Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye.
Kang Derwent JJ; Mieler WF
Trans Am Ophthalmol Soc; 2008; 106():206-13; discussion 213-4. PubMed ID: 19277236
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Bioactive Aflibercept In Vitro.
Liu W; Lee BS; Mieler WF; Kang-Mieler JJ
Curr Eye Res; 2019 Mar; 44(3):264-274. PubMed ID: 30295090
[TBL] [Abstract][Full Text] [Related]
3. Role of Thermo-responsiveness and Poly(ethylene glycol) Diacrylate Cross-link Density on Protein Release from Poly(N-isopropylacrylamide) Hydrogels.
Drapala PW; Brey EM; Mieler WF; Venerus DC; Kang Derwent JJ; Pérez-Luna VH
J Biomater Sci Polym Ed; 2011; 22(1-3):59-75. PubMed ID: 20540835
[TBL] [Abstract][Full Text] [Related]
4. Polyethylene glycol (PEG)-Poly(N-isopropylacrylamide) (PNIPAAm) based thermosensitive injectable hydrogels for biomedical applications.
Alexander A; Ajazuddin ; Khan J; Saraf S; Saraf S
Eur J Pharm Biopharm; 2014 Nov; 88(3):575-85. PubMed ID: 25092423
[TBL] [Abstract][Full Text] [Related]
5. Extended and sequential delivery of protein from injectable thermoresponsive hydrogels.
Nelson DM; Ma Z; Leeson CE; Wagner WR
J Biomed Mater Res A; 2012 Mar; 100(3):776-85. PubMed ID: 22237975
[TBL] [Abstract][Full Text] [Related]
6. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
[TBL] [Abstract][Full Text] [Related]
7. In situ antibody-loaded hydrogel for intravitreal delivery.
Awwad S; Abubakre A; Angkawinitwong U; Khaw PT; Brocchini S
Eur J Pharm Sci; 2019 Sep; 137():104993. PubMed ID: 31302214
[TBL] [Abstract][Full Text] [Related]
8. Antibody loaded collapsible hyaluronic acid hydrogels for intraocular delivery.
Egbu R; Brocchini S; Khaw PT; Awwad S
Eur J Pharm Biopharm; 2018 Mar; 124():95-103. PubMed ID: 29294367
[TBL] [Abstract][Full Text] [Related]
9. Regulating drug release from pH- and temperature-responsive electrospun CTS-g-PNIPAAm/poly(ethylene oxide) hydrogel nanofibers.
Yuan H; Li B; Liang K; Lou X; Zhang Y
Biomed Mater; 2014 Aug; 9(5):055001. PubMed ID: 25135109
[TBL] [Abstract][Full Text] [Related]
10. A biocompatible reverse thermoresponsive polymer for ocular drug delivery.
Balachandra A; Chan EC; Paul JP; Ng S; Chrysostomou V; Ngo S; Mayadunne R; van Wijngaarden P
Drug Deliv; 2019 Dec; 26(1):343-353. PubMed ID: 30905169
[TBL] [Abstract][Full Text] [Related]
11. Thermo-responsive hydrogel as an anti-VEGF drug delivery system to inhibit retinal angiogenesis in Rex rabbits.
Hu CC; Chiu YC; Chaw JR; Chen CF; Liu HW
Technol Health Care; 2019; 27(S1):153-163. PubMed ID: 31045535
[TBL] [Abstract][Full Text] [Related]
12. Refined control of thermoresponsive swelling/deswelling and drug release properties of poly(N-isopropylacrylamide) hydrogels using hydrophilic polymer crosslinkers.
Kim S; Lee K; Cha C
J Biomater Sci Polym Ed; 2016 Dec; 27(17):1698-1711. PubMed ID: 27573586
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the sustained release ability of bevacizumab-loaded tetra-PEG gel.
Murakami T; Hoshi S; Okamoto F; Sakai T; Katashima T; Naito M; Oshika T
Exp Eye Res; 2022 Oct; 223():109206. PubMed ID: 35921961
[TBL] [Abstract][Full Text] [Related]
14. Injectable Thermoresponsive Hydrogel Formed by Alginate-g-Poly(N-isopropylacrylamide) That Releases Doxorubicin-Encapsulated Micelles as a Smart Drug Delivery System.
Liu M; Song X; Wen Y; Zhu JL; Li J
ACS Appl Mater Interfaces; 2017 Oct; 9(41):35673-35682. PubMed ID: 28937214
[TBL] [Abstract][Full Text] [Related]
15. Biocompatible reverse thermal gel sustains the release of intravitreal bevacizumab in vivo.
Rauck BM; Friberg TR; Medina Mendez CA; Park D; Shah V; Bilonick RA; Wang Y
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):469-76. PubMed ID: 24370837
[TBL] [Abstract][Full Text] [Related]
16. Controlled and Extended In Vitro Release of Bioactive Anti-Vascular Endothelial Growth Factors from a Microsphere-Hydrogel Drug Delivery System.
Osswald CR; Kang-Mieler JJ
Curr Eye Res; 2016 Sep; 41(9):1216-22. PubMed ID: 26764892
[TBL] [Abstract][Full Text] [Related]
17. Development of a temperature-sensitive composite hydrogel for drug delivery applications.
Ramanan RM; Chellamuthu P; Tang L; Nguyen KT
Biotechnol Prog; 2006; 22(1):118-25. PubMed ID: 16454501
[TBL] [Abstract][Full Text] [Related]
18. The effect of glutathione as chain transfer agent in PNIPAAm-based thermo-responsive hydrogels for controlled release of proteins.
Drapala PW; Jiang B; Chiu YC; Mieler WF; Brey EM; Kang-Mieler JJ; Pérez-Luna VH
Pharm Res; 2014 Mar; 31(3):742-53. PubMed ID: 24022682
[TBL] [Abstract][Full Text] [Related]
19. Comparative Study of In Situ Loaded Antibody and PEG-Fab NIPAAM Gels.
Awwad S; Al-Shohani A; Khaw PT; Brocchini S
Macromol Biosci; 2018 Feb; 18(2):. PubMed ID: 29205853
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-Polycaprolactone Core-Shell Microparticles for Sustained Delivery of Bevacizumab.
Jiang P; Jacobs KM; Ohr MP; Swindle-Reilly KE
Mol Pharm; 2020 Jul; 17(7):2570-2584. PubMed ID: 32484677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
